Tyler Stone Wealth Management Novavax Inc Transaction History

Tyler Stone Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $742 - $4,005	-191 Reduced 20.43%	744 $9,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $2,820 - $4,515	750 Added 405.41%	935 $4,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $407 - $1,151	46 Added 33.09%	185 $2,000
Q2 2022 Aug 11, 2022	BUY	$36.28 - $75.29 $1,886 - $3,915	52 Added 59.77%	139 $7,000
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $3,207 - $6,573	46 Added 112.2%	87 $6,000
Q4 2021 Feb 22, 2022	BUY	$134.56 - $217.97 $5,516 - $8,936	41 New	41 $6,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Tyler Stone Wealth Management with notifications on news.